250 related articles for article (PubMed ID: 25904721)
1. Five-year risk of interval-invasive second breast cancer.
Lee JM; Buist DS; Houssami N; Dowling EC; Halpern EF; Gazelle GS; Lehman CD; Henderson LM; Hubbard RA
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25904721
[TBL] [Abstract][Full Text] [Related]
2. Cumulative Risk Distribution for Interval Invasive Second Breast Cancers After Negative Surveillance Mammography.
Lee JM; Abraham L; Lam DL; Buist DSM; Kerlikowske K; Miglioretti DL; Houssami N; Lehman CD; Henderson LM; Hubbard RA
J Clin Oncol; 2018 Jul; 36(20):2070-2077. PubMed ID: 29718790
[TBL] [Abstract][Full Text] [Related]
3. Mammographic density and risk of second breast cancer after ductal carcinoma in situ.
Habel LA; Capra AM; Achacoso NS; Janga A; Acton L; Puligandla B; Quesenberry CP
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2488-95. PubMed ID: 20929881
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer.
Buist DS; Abraham LA; Barlow WE; Krishnaraj A; Holdridge RC; Sickles EA; Carney PA; Kerlikowske K; Geller BM;
Breast Cancer Res Treat; 2010 Dec; 124(3):863-73. PubMed ID: 20700648
[TBL] [Abstract][Full Text] [Related]
5. Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees.
Fenton JJ; Xing G; Elmore JG; Bang H; Chen SL; Lindfors KK; Baldwin LM
Ann Intern Med; 2013 Apr; 158(8):580-7. PubMed ID: 23588746
[TBL] [Abstract][Full Text] [Related]
6. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
7. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
[TBL] [Abstract][Full Text] [Related]
8. Biennial versus annual mammography and the risk of late-stage breast cancer.
White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
[TBL] [Abstract][Full Text] [Related]
9. Association of Screening With Digital Breast Tomosynthesis vs Digital Mammography With Risk of Interval Invasive and Advanced Breast Cancer.
Kerlikowske K; Su YR; Sprague BL; Tosteson ANA; Buist DSM; Onega T; Henderson LM; Alsheik N; Bissell MCS; O'Meara ES; Lee CI; Miglioretti DL
JAMA; 2022 Jun; 327(22):2220-2230. PubMed ID: 35699706
[TBL] [Abstract][Full Text] [Related]
10. Predictors of surveillance mammography outcomes in women with a personal history of breast cancer.
Lowry KP; Braunstein LZ; Economopoulos KP; Salama L; Lehman CD; Gazelle GS; Halpern EF; Giess CS; Taghian AG; Lee JM
Breast Cancer Res Treat; 2018 Aug; 171(1):209-215. PubMed ID: 29748762
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
[TBL] [Abstract][Full Text] [Related]
12. Detection of ductal carcinoma in situ in women undergoing screening mammography.
Ernster VL; Ballard-Barbash R; Barlow WE; Zheng Y; Weaver DL; Cutter G; Yankaskas BC; Rosenberg R; Carney PA; Kerlikowske K; Taplin SH; Urban N; Geller BM
J Natl Cancer Inst; 2002 Oct; 94(20):1546-54. PubMed ID: 12381707
[TBL] [Abstract][Full Text] [Related]
13. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
Luke C; Priest K; Roder D
Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
[TBL] [Abstract][Full Text] [Related]
14. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy.
Cho N; Han W; Han BK; Bae MS; Ko ES; Nam SJ; Chae EY; Lee JW; Kim SH; Kang BJ; Song BJ; Kim EK; Moon HJ; Kim SI; Kim SM; Kang E; Choi Y; Kim HH; Moon WK
JAMA Oncol; 2017 Nov; 3(11):1495-1502. PubMed ID: 28655029
[TBL] [Abstract][Full Text] [Related]
16. The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ.
Robinson D; Holmberg L; Møller H
Br J Cancer; 2008 Aug; 99(4):611-5. PubMed ID: 18665169
[TBL] [Abstract][Full Text] [Related]
17. Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma.
Lee L; Pintilie M; Hodgson DC; Goss PE; Crump M
Ann Oncol; 2008 Jan; 19(1):62-7. PubMed ID: 17878177
[TBL] [Abstract][Full Text] [Related]
18. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
[TBL] [Abstract][Full Text] [Related]
19. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast.
Innos K; Horn-Ross PL
Breast Cancer Res Treat; 2008 Oct; 111(3):531-40. PubMed ID: 17978879
[TBL] [Abstract][Full Text] [Related]
20. Emerging Trends in Family History of Breast Cancer and Associated Risk.
Shiyanbola OO; Arao RF; Miglioretti DL; Sprague BL; Hampton JM; Stout NK; Kerlikowske K; Braithwaite D; Buist DSM; Egan KM; Newcomb PA; Trentham-Dietz A
Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1753-1760. PubMed ID: 28986348
[No Abstract] [Full Text] [Related]
[Next] [New Search]
